Verapamil Hcl
Brand name: Verapamil Er
Rank #487 of 500 drugs by total cost
$14.4M
Total Cost
329,950
Total Claims
$14.4M
Total Cost
17,547
Prescribers
$44
Cost per Claim
12,670
Beneficiaries
697,654
30-Day Fills
$820
Avg Cost/Provider
19
Avg Claims/Provider
About Verapamil Hcl
Verapamil Hcl (sold as Verapamil Er) was prescribed 329,950 times by 17,547 Medicare Part D providers in 2023, costing the program $14.4M. At $44 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 484 | Exemestane (Exemestane) | $14.5M | 66,285 |
| 485 | Dihydroergotamine Mesylate (Dihydroergotamine Mesylate) | $14.4M | 6,855 |
| 486 | Clotrimazole/Betamethasone Dip (Clotrimazole-Betamethasone) | $14.4M | 503,015 |
| 487 | Verapamil Hcl (Verapamil Er) | $14.4M | 329,950 |
| 488 | Eteplirsen (Exondys-51) | $14.4M | 192 |
| 489 | Colesevelam Hcl (Colesevelam Hcl) | $14.3M | 50,268 |
| 490 | Bexarotene (Bexarotene) | $14.2M | 1,613 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology